Drenger B

Language: English
References: 16
Page: 255-257
PDF size: 100.25 Kb.

Text Extraction

The patient with coronary artery disease (CAD) undergoing coronary artery surgery (CABG) presents a special challenge to the anesthesiologist. The combination of increased surgical stress response with limited coronary reserve exposes the patient to a special vulnerable situation during the perioperative period. Typically, the patients with CAD are older with higher rate of comorbidities and thus more sensitive for the development of hemodynamic instability and organ dysfunction. The current trend of more aggressive intra-coronary cardiological interventions in sicker patients creates a requirement for the development of more comprehensive approach to the perioperative management of these patients.

REFERENCES

1. Mangano DT, Siliciano D, Hollenberg M, et al. Postoperative myocardial ischemia. Therapeutic trials using intensive analgesia following surgery. The Study of Perioperative Ischemia Research Group. Anesthesiology 1992;76:342-53.

2. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001;87:684-90.

3. Wallace A, Layug B, Tateo I, et al, for the McSPI Research Group: Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998;88:7-17.

4. Chen J, Radford MJ, Wang Y, et al. Are beta - blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction? Arch Intern Med 2000;160:947-52.

5. Wallace AW, Galindez D, Salahieh A, et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 2004;101:284-93.

6. Collard CD, Body SC, Shernan SK, et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006;132:392-400.

7. Ferguson Jr TB, Coombs LP, Peterson ED. Preoperative beta - blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002;287:2221-7.

8. Coleman CI, Perkerson KA, Gillespie EL, et al. Impact of prophylactic postoperative betablockade on post - cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother 2004;38:2012-6-

9. Wallace AW, Fontes M, Drenger B, Wang S. McSPI Research Group: The Effect of anti - ischemic agents on morbidity and mortality after coronary artery bypass surgery. Anesthesiology 2003;99:A255.

10. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9.

11. Ryckwaert F, Colson P, Ribstein J, et al. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 2001;86:169-75.

12. Drenger B, Gozal Y, Fontes M, Mangano D. McSPI Research Group: The association between ACE inhibitors pattern of use and patient outcome after coronary artery bypass surgery. Anesthesiology A1737, 2006.

13. Cuthbertson BH, Croal BL, Rae D, et al- N - terminal pro -B - type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Br J Anaesth. 2009;103:647-53

14. Zaugg M, Lucchinetti E, Uecker M, et al. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003;91:551-65.

15. Drenger B, Gilon D, Chevion M, et al. Myocardial metabolism altered by ischemic preconditioning and enflurane anesthesia in off - pump coronary surgery. J Cardiothor Vasc Anesth 2008;22:369-76.

16. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 2005;100:1584-93.